-
公开(公告)号:AU657007B2
公开(公告)日:1995-02-23
申请号:AU2738592
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , C07D405/10 , C07D413/10 , C07D417/10
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:GB2280674A
公开(公告)日:1995-02-08
申请号:GB9415663
申请日:1994-08-03
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , STERNBACH DANIEL DAVID , UEHLING DAVID E , PROFETA JUNIOR SALVATORE
IPC: C07D491/22 , A61K31/435
Abstract: Camptothecin derivatives of formula (I> wherein R is hydrogen, alkyl, alkenyl or phenyl; Q is hydrogen, halogen, cyano, 5-tetrazolo, -COOR , -CONR R , -C(NH2)=NR , -CH=NNH2, -(CH2)nR , -CH=CH(CH2)nR or -C=C(CH2)nR wherein n is 0, 1, 2 or 3; R is hydrogen or alkyl; R and R independently represent hydrogen, alkyl, aminoalkyl or dialkylaminoalkyl; R is hydrogen, alkyl, hydroxy, alkoxy or -COOCH2NHCOO Bu; R is hydrogen, hydroxy, -NR R , -NHCOR or a nitrogen heterocycle of formula wherein R and R independently represent hydrogen or alkyl; R is alkyl or O-alkyl; Y is O, S, NR , CH2 or a direct linkage; R is hydrogen or alkyl; T is hydrogen or when Q is halogen T may also represent halogen; and X is a free electron pair, oxygen or alkyl; and pharmaceutically acceptable salts thereof, are topoisomerase inhibitors useful in the treatment of cancer. Pyridines of formula (II> wherein R* is methyl or ethyl Q is Br and T is H or Br; and derivatives corresponding to formula (I) but with the E ring open are novel intermediates.
-
公开(公告)号:NZ244914A
公开(公告)日:1995-01-27
申请号:NZ24491492
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , A61K31/47 , C07D319/18 , C07D491/22 , C07D498/22 , A61K31/44 , A61K31/445 , A61K31/495 , A61K31/535 , A61K31/54
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CA2161681A1
公开(公告)日:1994-11-10
申请号:CA2161681
申请日:1994-04-28
Applicant: GLAXO INC
IPC: A61K20060101 , A61K31/47 , A61P35/00 , C07D20060101 , C07D317/66 , C07D319/18 , C07D491/22 , A61K31/435 , C07D405/12 , C07D407/12
Abstract: The present invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R1 represents: hydrogen, lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, amino lower allcyl, lower alkylamino lower alkyl, amino lower alkyl, lower alkoxy lower alkyl or (CH2)tAr wherein: t is 0 to 5 and Ar represents phenyl, furyl, pyridyl, N-methylpyrrolyl, imidazolyl; or phenyl, furyl, pyridyl, N-methylpyrrolyl, imidazol, with one or more substituents independently selected from hydroxy, methoxy, halogen, and amino; and R2 represents: diphenylmethyl or (CH2)tAr; or ii) R1 and R2 taken together with the linking nitrogen represent N-tetrahydroquinolyl or N-tetrahydroisoquinolyl; and the pharmaceutically acceptable salts and solvates thereof, their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CA2148819A1
公开(公告)日:1994-05-26
申请号:CA2148819
申请日:1993-11-10
Applicant: GLAXO INC
Inventor: BESTERMAN JEFFREY MARK , EVANS MICHAEL GLENN , LACKEY KAREN ELIZABETH , LUZZIO MICHAEL JOSEPH , PEEL MICHAEL ROBERT , STERNBACH DANIEL DAVID
IPC: A61K31/47 , A61K31/675 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07F9/6561 , C07D405/12 , C07D413/12 , C07D417/12 , A61K31/395
Abstract: 2148819 9411377 PCTABScor01 The present invention relates to water soluble, camptothecin derivatives of formula (I), wherein A represents a moiety of formula (IIA), (IIB) or (IIC), X is selected from the group consisting of alkyl, aryl, (CH2)mOR1, (CH2)mSR1 and (CH2)mNR1R2 wherein m is an integer of 0 to 6, and R1 and R2 are hydrogen, lower alkyl, aryl or together with the nitrogen form a 5-7 membered ring; q is an integer of 0 to 2; n represents the integer 1 or 2; p is an integer of 1 to 6; Y and W are selected from the group consisting of alkyl, aryl, alkoxy, aryloxy and amino, Q is oxygen or sulfur; P is phosphorus; J represents the atoms necessary to complete a 5 or 6 membered aromatic ring; and the pharmaceutically acceptable salts thereof; their use as topoisomerase inhibitors, their preparation; and their use in the treatment of cancer.
-
公开(公告)号:OA9767A
公开(公告)日:1993-11-30
申请号:OA60295
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
CPC classification number: C07D319/18 , C07D317/66
-
公开(公告)号:CZ323792A3
公开(公告)日:1993-10-13
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:ZA9208324B
公开(公告)日:1993-05-04
申请号:ZA9208324
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:NO924158D0
公开(公告)日:1992-10-28
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/47 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , C07D
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
-
-
-
-
-
-
-